Aaids-150808104852-lva1-app6892 (1).pptx

neelamvashishtha88 7 views 58 slides Oct 26, 2025
Slide 1
Slide 1 of 58
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58

About This Presentation

aids-150808104852-lva1-app6892 (1).pptx


Slide Content

HIV/AIDS

AIDS Acquired immuno deficiency syndrome Fatal illness Caused by a retrovirus HIV It breaks down the body's immune system, leaving the patient vulnerable to a host of life threatening opportunistic infections, neurological disorders or unusual malignancies.

INTRODUCTION

INTRODUCTION

Structure of HIV

MORPHOLOGY

MORPHOLOGY

MORPHOLOGY

MORPHOLOGY

MORPHOLOGY

MORPHOLOGY

Epidemiology

19 AIDS Worldwide

HIV- Agent It is a RNA virus Which replicates in actively dividing T4 lymphocytes. Unique ability to destroy T4 Helper cells Reservoir- Once a person gets infected virus remains in his body lifelong. And the person is a symptomless carrier for years before the symptoms actually appear.

Source – The virus is found in great concentrations in blood, CSF and semen. Lower concentrations have been found in tears, saliva, breast milk, urine, cervical and vaginal secretions. Also isolated from brain tissue, lymph nodes, bone marrow cells and skin. However only blood and semen are known to transmit the virus.

22 HIV in Body Fluids Semen 11,000 Vaginal Fluid 7,000 Blood 18,000 Amniotic Fluid 4,000 Saliva 1 Average number of HIV particles in 1 ml of these body fluids

Host Age- Most cases are among sexually active people aged between age 20- 49 years. High risk groups- Male homosexuals, hetero sexual partners, i.v . drug abusers, blood transfusion recipients, haemophiliacs and patients having STDs.

24 HIV Transmission HIV enters the bloodstream through: Open Cuts Breaks in the skin Mucous membranes Direct injection

25 Routes of Transmission of HIV Sexual Contact: Male-to-male Male-to-female or vice versa Female-to-female Blood Exposure: Injecting drug use/needle sharing Occupational exposure Transfusion of blood products Perinatal : Transmission from mother to baby Breastfeeding

26 Routes of Transmission of HIV Occupational Transmission Health care worker/ hospital staff Laboratory workers Other routes Organ transplantation Artificial insemination Needle-prick

Incubation Period The incubation period is from HIV infection till development of AIDS. It is from a few months to 10 years or even more. However it is estimated that 75% of people infected with HIV will develop AIDS at the end of 10 years.

28 HIV-Infected T-Cell HIV Virus T-Cell HIV Infected T-Cell New HIV Virus

Clinical Manifestations I] Initial Infection II] Asymptomatic Carrier State III] AIDS-related Complex(ARC) IV] AIDS

I] Initial Infection Except for a generally mild illness of fever, sore throat and rash, which about 70% of the people experience a few weeks after the initial infection; Most HIV –infected people have no symptoms for the first five years. However they can infect others. Antibody Response usually takes 2-12 weeks to appear in the blood stream. This period is called ‘the window period’. (Tests- Negative)

34 HIV Infection And Antibody Response Infection Occurs AIDS Symptoms Initial Stage---------------- -------- Intermediate or Latent Stage- ------------- --- Illness Stage Flu-like Symptoms Or No Symptoms Symptom-free < ---- ----

35 The Acute HIV Syndrome Follows 3-6 wks following primary infection

Asymptomatic Carrier State Infected people with antibodies but without any overt signs of the disease, except persistent generalized lymphadenopathy. It is however not firmly clear about how long does the asymptomatic stage lasts.

AIDS-Related Complex Has illnesses caused by damage to immune system, but without the opportunistic infections and cancers associated with AIDS. They may exhibit- Unexplained diarrhea(lasting more than a month), fatigue, malaise, loss of body weight(>10%), fever, night sweats. Signs of Mild infections like oral thrush, generalized lymphadenopathy, enlarged spleen.

38 Common manifestation of AIDS Lung infection: P. Carinii pneumonia Gastrointestinal infection: candidiasis of mouth or oesophagus Skin infection: Kaposi’s sarcoma - red or violet macules or papules Central nervous System Infection: Toxoplasmosis Dementia Meningitis Primary CNS Lymphomas. Progressive Multifocal Leucoencephalopathy.

39 Source: NACO Opportunistic Infections Among Reported AIDS Cases in India

40

41 Kaposi sarcoma Candidiasis Of Mouth

Swollen parts of the body

Deterioration of the body tissues

44 Extreme Wt loss Lymphadenopathy

45 P. Carinii pneumonia Primary CNS Lymphoma

PREVENTION

47

Diagnosis of HIV HIV antibody test Viral antigen test - used for screening blood donors Detection of viral nucleic acid in blood. Determining the CD4 counts to assess the disease progression.

Testing- ICTC centre (Integrated Counseling & Testing Centre) District Hospitals Medical colleges Free HIV testing Confidential counseling Referral to nearest ART (Anti Retroviral Therapy) centre .

ANTIRETROVIRAL DRUGS NRTI NNRTI PI Zidovudine (AZT)* Nevirapine(NVP)* Indinavir(IDV)* Lamivudine (3TC)* Efavirenz (EFV)* Nelfinavir(NFV)* Stavudine (d4T)* Delavirdine(DLV) Saquinavir(SQV)* Didanosine ( ddl )* INTEGRASE INHIBITORS Ritonavir(RTV)* Zalcitabine(ddC)* Raltegravir Amprenavir(APV) Abacavir (ABC)* CCR5 antagonists Lopinavir (LPV)* Tenofovir (TFV )* Maraviroc Atazanavir (ATV )* Emtricitabine(FTC)   Foseamprenavir MAMC- Feb 2009 Fusion Inhibitor: Enfuvirtide (T-20) * Available in India , available under national programme

PREVENTION Avoid multiple partners – use Condoms. Use sterile needles each time for injection Never share needles Avoid unnecessary blood transfusions All pregnant women should be tested for HIV

Prevention Use standard work precautions – hand hygiene, personal protective gear. Proper disposal of biomedical waste Education

Occupational Exposure HCW comes in contact with potentially infectious body fluids due to – A percutaneous injury ( needle stick, cut with sharp object) Contact with mucous membrane Contact with non intact skin (abraded, chapped, dermatitis )

Management of Exposure site Do not panic Skin Wash wound & surrounding with soap/water Rinse well Do not scrub Do not use Antiseptic or Skin washes

Management of Exposure site Splash of Blood Eye Eye irrigation with water or Saline If using contact lens leave them in place while irrigating .Remove once eye is cleaned remove them & clean Mouth Spit fluid immediately Rinse mouth thoroughly with water / saline repeatedly Do not use soap or disinfectant

PEP Prescription Contact ART specialist Decision of starting PEP based on Exposure type & HIV status of source Decide PEP regimens

Post Exposure Prophylaxis In India recommended for occupational exposure It should be started as early as possible (within 72 hours) ARV is given for 4 weeks HIV testing should be done at baseline, 6wks, 3mths & 6mths

Thank you!